CURX MEXC RealStocks
Own real CURX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-18 09:12:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Curanex Pharmaceuticals Inc. (CURX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.60, with a market capitalization of $7.27M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.58 to $13.33. This page covers its latest market performance, valuation, price trends and company information.
$7.27M | |
$4.60 | |
$4.60 | |
$4.60 | |
$4.70 | |
-- | |
21.78K | |
-- | |
$13.33 | |
$3.58 | |
-- | |
-- |
Curanex Pharmaceuticals Inc. (CURX) is trading at $4.60 in pre-market trading as of 2026-11-18 09:00:00, down 2.15% ($0.10) from the previous close of $4.70
Pre-market trading shows how investors are pricing CURX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Curanex Pharmaceuticals Inc. (CURX) moved from $6.20 to $4.60, representing a decline of 25.82% ($1.60).
The stock traded between $4.59 and $6.20 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.03 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 10.5%
CURX is currently trading at $4.60, placing it 10.5% of the way from its 52-week low of $3.58 to its 52-week high of $13.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Curanex Pharmaceuticals Inc. (CURX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CURX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CURX shares and USD.
CURX Shares to USD
1.00 CURX shares = 4.599 USD
Calculations are estimates based on the latest available price and are for reference only.